CANGO Press Release | Pharmac Funding - sharechat.co.nz sharechat.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sharechat.co.nz Daily Mail and Mail on Sunday newspapers.
The $1.774 billion investment won’t cover the 13 new cancer drugs National promised it would fund, or any other new treatment on Pharmac’s Options for Investment list.
Life-saving treatment for deadliest form of breast cancer a step closer to being funded nzdoctor.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nzdoctor.co.nz Daily Mail and Mail on Sunday newspapers.
Hope is on the horizon for Kiwis with the most aggressive form of breast cancer now that Pharmac’s cancer advisors have recommended pembrolizumab (branded as Keytruda) be funded for both early and advanced triple negative breast cancer (TNBC). Between .